Mink Therapeutics
INKT · NASDAQ
$9.86+$0.30 (+3.14%)TodayMarket closed ·
Prev close $9.56
Who owns INKT
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 63.0% of INKT’s shares.
- Agenus, Inc.43.7%
- GKCC, LLC9.3%
- Armen (Garo H.)3.5%
- Vanguard Capital Management, LLC1.4%
- Next 6 largest institutions5.1%
- All other shareholders37.0%
| Holder | Shares | % of shares |
|---|---|---|
| Agenus, Inc. | 2.18M | 43.72% |
| GKCC, LLC | 464.00K | 9.32% |
| Armen (Garo H.) | 172.80K | 3.47% |
| Vanguard Capital Management, LLC | 68.66K | 1.38% |
| Buell (Jennifer) | 57.94K | 1.16% |
| DNB Asset Management AS | 55.14K | 1.11% |
| Corvese (Brian J) | 51.50K | 1.03% |
| Wiinberg Ulf | 49.20K | 0.99% |
| Behner (Peter) | 21.43K | 0.43% |
| Ryan (Barbara) | 20.34K | 0.41% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| DNB Fund Disruptive Opportunities | 55.14K | 1.11% |
| Vanguard Total Stock Market Index Fund | 53.07K | 1.07% |
| Vanguard Extended Market Index Fund | 15.38K | 0.31% |
| iShares Micro-Cap ETF | 6.82K | 0.14% |
| Fidelity Extended Market Index Fund | 6.79K | 0.14% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $92.41K (3 trades) of INKT on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Buell Jennifer | Sale | 6.94K | $73.27K |
| Buell Jennifer | Option exercise | 23.19K | — |
| Buell Jennifer | Option exercise | 23.19K | — |
| Holcomb John Bradley | Award | 1.23K | $13.50K |
| Behner Peter | Award | 1.49K | $16.26K |
| Ryan Barbara | Award | 1.62K | $17.76K |
| Corvese Brian | Award | 1.63K | $17.88K |
| WIINBERG ULF | Award | 1.28K | $14.01K |
| Ryan Barbara | Sale | 1.00K | $12.80K |
| Ryan Barbara | Sale | 500 | $6.34K |
Short interest
Settled Sep 30, 2026
- Shares short
- 49.58K
- Days to cover
- 3.12
- % of shares outstanding
- 1.00%
- Average daily volume
- 15.90K
- Change since last report
- −13.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.